Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Bimosiamose prolongs rat kidney allograft survival by reducing intragraft cytokine production

Aug. 28, 2002

CD45RB MAb prolongs allograft survival in mice

Aug. 28, 2002

IL-10 gene therapy prevents recurrence of autoimmune diabetes after islet transplantation

Aug. 28, 2002

Ishihara Sangyo describes new inhibitors of Th1 and/or Th2 cytokine production

Aug. 26, 2002

HGF, a rapid diagnostic marker and preventative treatment for acute renal rejection

Aug. 23, 2002

New cathepsin S inhibitors designed by Boehringer Ingelheim researchers

Aug. 21, 2002

Wyeth scientists identify novel inhibitors of B7.1-CD28 interaction

Aug. 21, 2002

CAT and Xerion enter allergy target research collaboration

Aug. 21, 2002

ProdiGene and NIAID to begin phase I trial of oral traveler's diarrhea vaccine

Aug. 20, 2002

Novel ITK tyrosine kinase inhibitors and their use covered by BMS patent

Aug. 13, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...